Three weeks ago, the Department of Health (DOH) approved the recommendation of the Health Technology Assessment Council (HTAC) to give a fourth dose or second booster of the COVID-19 vaccines AstraZeneca, Sinovac, Pfizer-BioNTech, Moderna, and Sinopharm to the immunocompromised population for ages 18 years old and above. These include those receiving cancer treatment, immunosuppressants, and those […]